Yoshitaka Shimizu
Kissei Pharmaceutical Co., Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yoshitaka Shimizu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:44 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07015268 · A Clinical Study of KLH-2109 in Patients With EndometriosisKissei Pharmaceutical Co., Ltd. · active not recruiting · Endometriosis · study director
- Ph2NCT06722729 · A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseKissei Pharmaceutical Co., Ltd. · completed · Parkinson Disease · study director
- Ph2NCT05831670 · An Early Phase 2 Clinical Study of KSP-0243Kissei Pharmaceutical Co., Ltd. · completed · Colitis, Ulcerative · study director
- Ph3NCT05445167 · A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and PainKissei Pharmaceutical Co., Ltd. · completed · Uterine Fibroids (MeSH Heading: Leiomyoma) · study director
- Ph3NCT05440383 · A Clinical Study of KLH-2109 in Uterine Fibroids Patient With MenorrhagiaKissei Pharmaceutical Co., Ltd. · completed · Uterine Fibroids (MeSH Heading: Leiomyoma) · study director
- Ph2NCT04867551 · A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseKissei Pharmaceutical Co., Ltd. · completed · Parkinson Disease · study director
- Ph3NCT04711603 · A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.Kissei Pharmaceutical Co., Ltd. · completed · Uremic Pruritus · study director
- Ph3NCT04132050 · A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788Kissei Pharmaceutical Co., Ltd. · completed · Idiopathic Thrombocytopenic Purpura · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:44 UTC. The ranking covers the 200 most relevant of 162 PubMed records, and a shared surname and initials can bring in a namesake. All 162 on PubMed
- 931 citationsRCR 34.4
- Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.Br J Surg · 2018347 citationsRCR 14.2
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.Lancet Neurol · 2020296 citationsRCR 16.4
- 230 citationsRCR 26.4
- Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.J Clin Oncol · 2021203 citationsRCR 12.3
- Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.Gastroenterology · 2016181 citationsRCR 7.0
- C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis.Circulation · 2001173 citationsRCR 4.3
- Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction.Am J Gastroenterol · 2011130 citationsRCR 6.2
- Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors.J Ultrasound Med · 2005114 citationsRCR 3.9
- 96 citationsRCR 4.4